A research survey was conducted to find out which diagnostic classification systems were commonly used in university hospitals in Japan. By using a questionnaire, we collected data to determine which diagnostic classification systems and diagnostic criteria were being used to identify schizophrenia, affective (mood) disorders, and neurosis. The results indicated that most university hospitals used either the International Classification of Diseases (ICD) of the WHO or the Diagnostic and Statistical Manual of Mental Disorders (DSM) of the American Psychiatric Association. For research of academic presentations, more than 60% of the surveyed institutions used DSM. In clinical settings, however, ICD and DSM were used with similar frequencies (42–43%). It was also noted that 15% of institutions still use a traditional psychiatric diagnosis for schizophrenia and mood disorders. This paper addresses historical aspects of the diagnosis and classification of mental illness in Japan.

Keywords:
International classification system, DSM, ICD, Internet, Japan
This content is only available via PDF.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.